Table 1

Clinical characteristics of primary AIHA patients

N*
Patients, N 308 
Male/female 111 (36)/197 (64) 
Median age at onset, y (range) 58 (0-95) 
 <18 y 10 (3) 
 18-45 y 73 (24) 
 45-65 y 104 (34) 
 >65 y 121 (39) 
AIHA serological type**  
 Warm, DAT positive for IgG 131 (43) 
 Warm, DAT positive for IgG+C 52 (17) 
 CAD 84 (27) 
 Mixed 24 (8) 
 Atypical 16 (5) 
Median follow-up, mo (range) 33 (6-372) 
Alive/dead at time of study 221 (72)/63 (21) 
Died of AIHA 11/63 (17) 
N*
Patients, N 308 
Male/female 111 (36)/197 (64) 
Median age at onset, y (range) 58 (0-95) 
 <18 y 10 (3) 
 18-45 y 73 (24) 
 45-65 y 104 (34) 
 >65 y 121 (39) 
AIHA serological type**  
 Warm, DAT positive for IgG 131 (43) 
 Warm, DAT positive for IgG+C 52 (17) 
 CAD 84 (27) 
 Mixed 24 (8) 
 Atypical 16 (5) 
Median follow-up, mo (range) 33 (6-372) 
Alive/dead at time of study 221 (72)/63 (21) 
Died of AIHA 11/63 (17) 
*

Values are n (%) unless otherwise indicated.

**

One patient of 308 studied was diagnosed with paroxysmal cold hemoglobinuria and not included in the subsequent analysis.

A total of 23 cases (7%) cases were lost at follow-up.

Close Modal

or Create an Account

Close Modal
Close Modal